drugset / Trial / NCT00291187
VEC-162 Study in Healthy Adult Volunteers in a Model of Insomnia
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine the safety and efficacy of VEC-162 compared to placebo to improve sleep parameters in a model of insomnia.
Timeline
- Start
- 2006-02
- Primary completion
- 2006-08
- Completion
- 2006-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | tasimelteon | Small molecule | 20 mg | Oral |
| Subject | tasimelteon | Small molecule | 50 mg | Oral |
| Subject | tasimelteon | Small molecule | 100 mg | Oral |